Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. (RANI) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 124 transactions totaling $114.1M, demonstrating a bullish sentiment with $58.0M in net insider flow. The most recent transaction on Oct 23, 2025 involved a purchase of 2,083,334 shares valued at $1.3M.
RANI Insider Activity Summary
Who Is Buying RANI Stock?
No significant insider buying has been recorded for RANI in the recent period.
Who Is Selling RANI Stock?
No significant insider selling has been recorded for RANI in the recent period.
Is Rani Therapeutics Holdings, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RANI is bullish with an Insider Alignment Score of 75/100 and a net flow of $58.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
RANI Frequently Asked Questions
Understanding RANI Insider Activity
Insider trading at Rani Therapeutics Holdings, Inc. (RANI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading RANI stock, having executed 124 transactions in the past 90 days. The most active insider is Moreno Isidoro Quiroga (Executive), who has made 3 transactions totaling $71.1M.
Related Tools
Track Rani Therapeutics Holdings, Inc. Insider Activity
Get notified when executives and directors at RANI file new Form 4 transactions